Health authorities must move with speed to establish reasons for the rising cases of resistance to commonly used drugs by patients across the country.
Several studies have conclusively established that patients are developing resistance to drugs commonly used to treat malaria, HIV and pneumonia. In June, the Kenya Medical Research Institute (KEMRI) declared that the number one malaria treatment based on the compound artemisinin had lost its efficacy.